CD44 and neoplasm: Very recently, we have shown that there is a strong correlation between the predominant CD44 isoform and RG7356-mediated tumor growth inhibition [22], where the co-expression of any variable exon (“CD44v”) on a tumor cell is predictive for unresponsiveness, probably due to favorable cellular gained functions that arise from CD44v interactions in cis with other survival relevant receptors.